| Key Financial Ratios of IOL Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
63.51 |
42.11 |
4.93 |
0.83 |
-7.60 |
|
| Diluted EPS (Rs.) |
63.38 |
42.11 |
4.93 |
0.83 |
-7.60 |
|
| Cash EPS (Rs.) |
69.79 |
47.31 |
10.30 |
6.14 |
-1.84 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
143.00 |
83.38 |
38.38 |
33.57 |
32.94 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
143.00 |
83.38 |
38.38 |
33.57 |
32.94 |
|
| Dividend / Share(Rs.) |
3.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
333.01 |
296.24 |
174.93 |
126.43 |
103.27 |
|
| PBDIT/Share (Rs.) |
103.69 |
73.83 |
22.39 |
18.40 |
9.36 |
|
| PBIT/Share (Rs.) |
97.41 |
68.13 |
17.02 |
13.10 |
4.08 |
|
| PBT/Share (Rs.) |
93.73 |
59.09 |
5.57 |
1.05 |
-6.86 |
|
| Net Profit/Share (Rs.) |
63.51 |
41.61 |
4.93 |
0.83 |
-7.12 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
31.13 |
24.92 |
12.79 |
14.55 |
9.06 |
|
| PBIT Margin (%) |
29.25 |
22.99 |
9.72 |
10.35 |
3.94 |
|
| PBT Margin (%) |
28.14 |
19.94 |
3.18 |
0.83 |
-6.64 |
|
| Net Profit Margin (%) |
19.07 |
14.04 |
2.81 |
0.65 |
-6.89 |
|
| Return on Networth / Equity (%) |
44.40 |
49.90 |
12.83 |
2.47 |
-21.62 |
|
| Return on Capital Employed (%) |
62.03 |
56.58 |
18.84 |
14.99 |
-8.13 |
|
| Return on Assets (%) |
30.73 |
25.13 |
3.37 |
0.57 |
-5.15 |
|
| Total Debt/Equity (X) |
0.07 |
0.54 |
1.82 |
2.26 |
2.37 |
|
| Asset Turnover Ratio (%) |
161.15 |
178.93 |
119.66 |
86.93 |
74.80 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
2.38 |
1.90 |
1.26 |
1.27 |
1.27 |
|
| Quick Ratio (X) |
1.71 |
1.16 |
0.60 |
0.46 |
0.47 |
|
| Inventory Turnover Ratio (X) |
10.10 |
8.92 |
4.74 |
2.71 |
2.55 |
|
| Dividend Payout Ratio (NP) (%) |
5.69 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
5.18 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
94.31 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
94.82 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
903.39 |
1,310.62 |
821.04 |
763.91 |
857.28 |
|
| EV/Net Operating Revenue (X) |
0.48 |
0.78 |
0.83 |
1.07 |
1.48 |
|
| EV/EBITDA (X) |
1.53 |
3.12 |
6.52 |
7.38 |
16.30 |
|
| MarketCap/Net Operating Revenue (X) |
0.53 |
0.64 |
0.45 |
0.50 |
0.74 |
|
| Retention Ratios (%) |
94.30 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
1.23 |
2.28 |
2.07 |
1.88 |
2.32 |
|
| Price/Net Operating Revenue |
0.53 |
0.64 |
0.45 |
0.50 |
0.74 |
|
| Earnings Yield |
0.36 |
0.22 |
0.06 |
0.01 |
-0.09 |
|
Source : Dion Global Solutions Limited
